To study and compare the side effects of one drug vs more than one drug in the treatment for schizophrenia.
Not Applicable
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2022/12/048297
- Lead Sponsor
- Department of psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ï?±Patients meeting diagnostic criteria of Schizophrenia according to ICD 11.
ï?±Patients of age 18 or above
ï?±Patients on nicotine and caffeine.
ï?±On stable antipsychotic dose for more than 2 weeks.
ï?±Patients/legally acceptable representatives willing to give written informed consent for participating in the study
Exclusion Criteria
ï?±Symptoms are a manifestation of another health condition(eg organic like brain tumour)
ï?±Symptoms are a manifestation of drug intoxication or withdrawal including Substance Dependence (eg alcohol) (Nicotine and caffeine users included in the study)
ï?±Pregnancy and postpartum period.
ï?±Patients on clozapine.
ï?±Patients on any other class of drugs except Benzodiazepines and antiparkinsonian drugs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iverpool University neuroleptic side effects rating scale <br/ ><br>Barnes akathisia rating scale <br/ ><br>Abnormal involuntary movement scale <br/ ><br>Simpson Angus scale <br/ ><br> <br/ ><br>Timepoint: 20 months <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable